• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

International circulation of aztreonam/avibactam-resistant NDM-5-producing Escherichia coli isolates: successful epidemic clones.

作者信息

Sadek Mustafa, Ruppé Etienne, Habib Amina, Zahra Rabaab, Poirel Laurent, Nordmann Patrice

机构信息

Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Department of Food Hygiene and Control, Faculty of Veterinary Medicine, South Valley University, Qena 83523, Egypt.

Université de Paris, IAME, INSERM, 75018 Paris, France.

出版信息

J Glob Antimicrob Resist. 2021 Dec;27:326-328. doi: 10.1016/j.jgar.2021.09.016. Epub 2021 Nov 18.

DOI:10.1016/j.jgar.2021.09.016
PMID:34800710
Abstract
摘要

相似文献

1
International circulation of aztreonam/avibactam-resistant NDM-5-producing Escherichia coli isolates: successful epidemic clones.产NDM-5的耐氨曲南/阿维巴坦大肠杆菌分离株的国际传播：成功的流行克隆株
J Glob Antimicrob Resist. 2021 Dec;27:326-328. doi: 10.1016/j.jgar.2021.09.016. Epub 2021 Nov 18.
2
Occurrence of Aztreonam-Avibactam-Resistant NDM-5-Producing Escherichia coli in the Food Chain.食物链中出现对氨曲南-阿维巴坦耐药且产NDM-5的大肠杆菌
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0088221. doi: 10.1128/AAC.00882-21.
3
Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3.对氨曲南/阿维巴坦敏感性降低的大肠埃希菌NDM分离株的特征分析：PBP3中一种新插入序列的作用
J Antimicrob Chemother. 2015 May;70(5):1420-8. doi: 10.1093/jac/dku568. Epub 2015 Jan 28.
4
Recent Emergence of Aztreonam-Avibactam Resistance in NDM and OXA-48 Carbapenemase-Producing Escherichia coli in Germany.德国产NDM和OXA-48碳青霉烯酶的大肠杆菌中氨曲南-阿维巴坦耐药性的近期出现
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0109021. doi: 10.1128/AAC.01090-21. Epub 2021 Aug 23.
5
Unusual Escherichia coli PBP 3 Insertion Sequence Identified from a Collection of Carbapenem-Resistant Enterobacteriaceae Tested with a Combination of Ceftazidime-, Ceftaroline-, or Aztreonam-Avibactam.从一组经头孢他啶、头孢洛林或氨曲南-阿维巴坦联合检测的耐碳青霉烯类肠杆菌科细菌中鉴定出异常的大肠杆菌PBP 3插入序列。
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00389-17. Print 2017 Aug.
6
Genetic Features Leading to Reduced Susceptibility to Aztreonam-Avibactam among Metallo-β-Lactamase-Producing Escherichia coli Isolates.产金属β-内酰胺酶的大肠埃希菌分离株中导致对阿维巴坦-氨曲南敏感性降低的遗传特征
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.01659-20.
7
In vitro activity of aztreonam-avibactam against metallo-β-lactamase-producing Enterobacteriaceae-A multicenter study in China.中国多中心研究：注射用氨曲南-阿维巴坦对产金属β-内酰胺酶肠杆菌科细菌的体外活性。
Int J Infect Dis. 2020 Aug;97:11-18. doi: 10.1016/j.ijid.2020.05.075. Epub 2020 May 28.
8
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing .头孢他啶-阿维巴坦对产碳青霉烯酶的. 的体外和体内杀菌活性。
Antimicrob Resist Infect Control. 2018 Nov 21;7:142. doi: 10.1186/s13756-018-0435-9. eCollection 2018.
9
Phenotypic synergy testing of ceftazidime-avibactam with aztreonam in a university hospital having high number of metallobetalactamase producing bacteria.在一所金属β-内酰胺酶产生菌数量较高的大学医院中，对头孢他啶-阿维巴坦与氨曲南进行表型协同试验。
Infect Dis (Lond). 2020 Nov;52(11):801-807. doi: 10.1080/23744235.2020.1788224. Epub 2020 Jul 6.
10
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates.氨曲南-阿维巴坦和对照药物对当代（2016 年）临床肠杆菌科分离株的抗菌活性。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01856-17. Print 2018 Jan.

引用本文的文献

1
Combined resistance mechanisms leading to high-level of cefiderocol resistance among NDM-like producing E. coli ST167 clinical isolates.导致产NDM样的大肠杆菌ST167临床分离株对头孢地尔产生高水平耐药的联合耐药机制。
Eur J Clin Microbiol Infect Dis. 2025 May 27. doi: 10.1007/s10096-025-05166-w.
2
Emergence and polyclonal dissemination of NDM-5/OXA-181 carbapenemase-producing Escherichia coli in the French Indian Ocean territories.印度洋法国海外领地中产生NDM-5/OXA-181碳青霉烯酶的大肠杆菌的出现及多克隆传播
Ann Clin Microbiol Antimicrob. 2025 Jan 29;24(1):8. doi: 10.1186/s12941-025-00778-8.
3
Effect of modification of penicillin-binding protein 3 on susceptibility to ceftazidime-avibactam, imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam, cefepime-taniborbactam, and cefiderocol of strains producing broad-spectrum β-lactamases.
产广谱β-内酰胺酶菌株中青霉素结合蛋白 3 修饰对头孢他啶-阿维巴坦、亚胺培南-雷巴坦、美罗培南-沃巴坦、氨曲南-阿维巴坦、头孢吡肟-他唑巴坦和头孢地尔的敏感性的影响。
Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0154823. doi: 10.1128/aac.01548-23. Epub 2024 Feb 28.
4
Activities and Inoculum Effects of Cefiderocol and Aztreonam-Avibactam against Metallo-β-Lactamase-Producing .头孢地尔与头孢他啶-阿维巴坦对产金属β-内酰胺酶的. 的活性和接种物效应。
Microbiol Spectr. 2023 Jun 15;11(3):e0056923. doi: 10.1128/spectrum.00569-23. Epub 2023 May 8.
5
In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates.头孢吡肟/齐他培南和头孢吡肟/替加环素对产 NDM 样酶超广谱β-内酰胺酶大肠埃希菌临床分离株的体外活性。
J Antimicrob Chemother. 2023 May 3;78(5):1191-1194. doi: 10.1093/jac/dkad061.
6
Genomic Characterization of an Extensively Drug-Resistant Extra-Intestinal Pathogenic (ExPEC) Clinical Isolate Co-Producing Two Carbapenemases and a 16S rRNA Methylase.一株同时产生两种碳青霉烯酶和一种16S rRNA甲基化酶的广泛耐药性肠外致病性（ExPEC）临床分离株的基因组特征分析
Antibiotics (Basel). 2022 Oct 26;11(11):1479. doi: 10.3390/antibiotics11111479.